<i>TERT</i> Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients

<i>TERT</i> Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients

Telomerase reverse transcriptase gene promoter (<i>TERTp</i>) mutations are recognized as one of the most frequent genetic events in bladder cancer (BC). No studies have focused on the relevance of TERTp mutations in the specific group of tumors treated with Bacillus Calmette&#8722;G...

Full description

Bibliographic Details
Main Authors: Rui Batista, Luís Lima, João Vinagre, Vasco Pinto, Joana Lyra, Valdemar Máximo, Lúcio Santos, Paula Soares
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:International Journal of Molecular Sciences
Subjects:
<i>tert</i> promoter mutations
<i>fgfr3</i>
non muscle invasive bladder cancer
bcg therapy
Online Access:https://www.mdpi.com/1422-0067/21/3/947

Internet

https://www.mdpi.com/1422-0067/21/3/947

Similar Items